Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Johnson Investment Counsel Inc.

Johnson Investment Counsel Inc. decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,545 shares of the medical equipment provider’s stock after selling 49 shares during the quarter. Johnson Investment Counsel Inc.’s holdings in Intuitive Surgical were worth $13,855,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in ISRG. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $31,000. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the third quarter worth approximately $33,000. Finally, Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $36,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ISRG. Barclays lifted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Raymond James lifted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Finally, Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,579 shares of company stock worth $7,756,844 in the last 90 days. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Trading Down 3.8 %

Shares of ISRG stock opened at $518.26 on Monday. The stock has a 50 day moving average of $571.36 and a two-hundred day moving average of $531.85. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a market capitalization of $184.59 billion, a P/E ratio of 80.85, a P/E/G ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.